Literature / General

FDA Issues ‘Safety Communication’ on Fenofibrate

FDA Issues 'Safety Communication' on Fenofibrate The US FDA has issued a safety communication and updated the prescribing information for the cholesterol-lowering agent fenofibric acid (Trilipix, Abbott), stating that the drug may not lower the risk of major...

Role of Behavioral Medicine in Primary Care

Role of Behavioral Medicine in Primary Care Mitchell D. Feldman MD, MPhil; Seth A. BerkowitzCurr Opin Psychiatry. 2012;25(2):121-127. © 2012 Lippincott Williams & Wilkins Abstract Purpose of review Behavioral medicine is a vast field with an ever-increasing...